DL-Pyroglutamic acid
CAS No. 149-87-1
DL-Pyroglutamic acid( —— )
Catalog No. M28638 CAS No. 149-87-1
DL-Pyroglutamic acid exhibited a strong inactivating effect on hepatitis B surface antigen.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 29 | In Stock |
|
| 5MG | 49 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDL-Pyroglutamic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionDL-Pyroglutamic acid exhibited a strong inactivating effect on hepatitis B surface antigen.
-
DescriptionDL-Pyroglutamic acid exhibited a strong inactivating effect on hepatitis B surface antigen.
-
In VitroDL-Pyroglutamic acid results 50 and 100% inactivation of the antigen of 0.01-0.025% and 0.025-0.05%, respectively.DL-Pyroglutamic acid is a possible glutamate antagonist, blocks glutamate miniature-end-plate potential in locust muscle-Druce and Bradford.
-
In VivoDL-Pyroglutamic acid (0.775 mM/L) completely abolishes the myoclonic jerks and EEG spikes in rats model of epileptic by cobalt implantation in the sensorimotor cerebral cortex.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorPyroptosis|Caspase-1|IL-1β|inflammation
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number149-87-1
-
Formula Weight129.114
-
Molecular FormulaC5H7NO3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (774.53 mM)
-
SMILESO=C(O)C(CC1)NC1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
(S)-Leucic acid
Hydroxyisocaproic acid is an end product of leucine metabolism in human tissues such as muscle and connective tissue. It belongs to 2-hydroxycarboxylic acid group of amino acid metabolites. Hydroxyisocaproic acid functions as an “anti-catabolite” and is widely used in the bodybuilding community.
-
UUN44923
UUN44923 is a FTO inhibitor.?It may be useful for treating diseases assocd.?with FTO targets, obesity, metabolic syndrome (MS) , type 2 diabetes (T2D) , Alzheimer's diseases, breast cancers, small- cell lung cancers, a human bone marrow striated muscle cancer, a pancreatic cancer, malignant glioblastoma and the like.?
-
8-Hydroxyquinoline-2...
8-Hydroxyquinoline-2-carbaldehyde is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
Cart
sales@molnova.com